 |
|
|
| |
Comorbidities, Comedication, and Polypharmacy Burden in
Patients With HIV: Retrospective Claims Data in Germany
|
| |
| |
Reported by Jules Levin
Glasgow 2018
Sara Lopes,1Kellie Meyer,2Sebastian Braun,3Yogesh Punekar,1Matthew Radford,1Jennifer Scarlet Haas3
1ViiV Healthcare, London, UK; 2Xcenda LLC, Boston, MA, USA; 3Xcenda GmbH, Hannover, Germany
High rates of mood/emotional disorders & greater in women HIV+ - Impact of HIV on quality of life: Preliminary data exploring differences by sex and country (UK and US) using the HIV Dependent Quality of Life questionnaire (HIVDQoL) - (11/02/18)
• HIV+ Over 50 taking on average 10 [up to 16] non-ART co-medications compared to 5.8 for HIV+ 35-49 age & 4.1 for those aged 18-34
• 60% to 70% of HIV+ >50 had ≥5 comorbidities: 26% CNS disorders; 26% hypertension; 7.5% kidney disorders; 13% osteoporosis; 21% CVD; 10% smoking, 5% BMI >30
60% to 70% of HIV+ >50 had ≥5 comorbidities
"Median numbers of existing chronic and acute conditions with diagnosis code throughout
2016 were 5 (range, 0-15) for the overall population and 6 (range, 0-15) for patients aged ≥ 50 years, but no difference was observed in patients taking ART for ≥5 years
• Acute respiratory infections and mood and anxiety disorders were the most prevalent conditions in the overall population, but hypertensive diseases were more prevalent in older PLHIV"
|
| |
|
|
|
|
|
